Ratings changes for Anavex Life Sciences, Apple, OPKO Health, Luna Innovations, RAPT Therapeutics, ACV Auctions, Celsius and moreâŠUpgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more.  Start Your Free Trial.
Apple (NASDAQ:AAPL) had its price target raised by analysts at Wedbush (Â Â Â Â ) from $300.00 to $325.00. They now have an âoutperformâ rating on the stock. This represents a 25.9% upside from the current price of $258.20.
Meta Platforms, Inc. (NASDAQ:META) declared a quarterly dividend on Thursday, December 5th. Investors of record on Monday, December 16th will be paid a dividend of 0.50 per share by the social networking company on Friday, December 27th. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date of this dividend is Monday, December 16th.
EverQuote (NASDAQ:EVER) was upgraded by analysts at Raymond James from an âoutperformâ rating to a âstrong-buyâ rating. They now have a $35.00 price target on the stock. This represents a 76.8% upside from the current price of $19.80.
Progressive (NYSE:PGR) was upgraded by analysts at Raymond James from a âmarket performâ rating to an âoutperformâ rating. They now have a $305.00 price target on the stock. This represents a 25.7% upside from the current price of $242.65.
RAPT Therapeutics (NASDAQ:RAPT) was upgraded by analysts at HC Wainwright from a âneutralâ rating to a âbuyâ rating. They now have a $10.00 price target on the stock. This represents a 444.7% upside from the current price of $1.84.
Hagerty (NYSE:HGTY) was downgraded by analysts at Raymond James from a âmarket performâ rating to an âunderperformâ rating.The current price is $9.84.
Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at HC Wainwright. They set a âbuyâ rating and a $38.00 price target on the stock. This represents a 222.0% upside from the current price of $11.80.
Sign up for MarketBeat All Access to gain access to MarketBeatâs full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeatâs trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See whatâs happening in the market right now with MarketBeatâs real-time news feed. Export data to Excel for your own analysis.
